在常规筛查的劳动力中，BNT162b2 疫苗接种后的无症状和有症状 SARS-CoV-2 感染。
Asymptomatic and Symptomatic SARS-CoV-2 Infections After BNT162b2 Vaccination in a Routinely Screened Workforce.
机构信息
Department of Biostatistics, St Jude Children's Research Hospital, Memphis, Tennessee.
Department of Infectious Diseases, St Jude Children's Research Hospital, Memphis, Tennessee.
出版信息
JAMA. 2021 Jun 22;325(24):2500-2502. doi: 10.1001/jama.2021.6564.
Abstract
This study aims to describe an association between the Pfizer-BioNTech (BNT162b2) vaccine and decreased risk of symptomatic and asymptomatic infections with SARS-CoV-2 in hospital employees.
摘要
本研究旨在描述辉瑞-生物科技（BNT162b2）疫苗与医院员工中症状性和无症状性 SARS-CoV-2 感染风险降低之间的关联。
相似文献
1
Asymptomatic and Symptomatic SARS-CoV-2 Infections After BNT162b2 Vaccination in a Routinely Screened Workforce.在常规筛查的劳动力中，BNT162b2 疫苗接种后的无症状和有症状 SARS-CoV-2 感染。
JAMA. 2021 Jun 22;325(24):2500-2502. doi: 10.1001/jama.2021.6564.
2
Asymptomatic SARS-CoV-2 Vaccine Breakthrough Infections in Health Care Workers Identified Through Routine Universal Surveillance Testing.通过常规普遍监测检测发现的医护人员中无症状的新冠病毒疫苗突破性感染
Ann Intern Med. 2021 Dec;174(12):1770-1772. doi: 10.7326/M21-3486. Epub 2021 Oct 19.
3
Asymptomatic and Symptomatic COVID-19 Infections Among Health Care Personnel Before and After Vaccination.接种疫苗前后医护人员无症状和有症状的 COVID-19 感染。
JAMA Netw Open. 2021 Jul 1;4(7):e2115980. doi: 10.1001/jamanetworkopen.2021.15980.
4
Incident SARS-CoV-2 Infection among mRNA-Vaccinated and Unvaccinated Nursing Home Residents.接种mRNA疫苗和未接种疫苗的养老院居民中SARS-CoV-2感染事件
N Engl J Med. 2021 Jul 29;385(5):474-476. doi: 10.1056/NEJMc2104849. Epub 2021 May 19.
5
Mass screening of healthcare personnel for SARS-CoV-2 in the Northern Emirates.阿联酋北部对医护人员进行新冠病毒大规模筛查。
J Hosp Infect. 2021 Feb;108:52-54. doi: 10.1016/j.jhin.2020.10.008. Epub 2020 Oct 17.
6
Symptomatic SARS-CoV-2 infections after full schedule BNT162b2 vaccination in seropositive healthcare workers: a case series from a single institution.血清阳性医护人员完成 BNT162b2 全程接种后出现有症状的 SARS-CoV-2 感染：来自单一机构的病例系列研究。
Emerg Microbes Infect. 2021 Dec;10(1):1254-1256. doi: 10.1080/22221751.2021.1942230.
7
Systematic screening on admission for SARS-CoV-2 to detect asymptomatic infections.入院时对 SARS-CoV-2 的系统性筛查，以检测无症状感染。
Antimicrob Resist Infect Control. 2021 Feb 27;10(1):44. doi: 10.1186/s13756-021-00912-z.
8
Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study.立陶宛血液系统恶性肿瘤患者的 BNT162b2 COVID-19 mRNA 疫苗免疫原性和早期临床结局：一项全国前瞻性队列研究。
Lancet Haematol. 2021 Aug;8(8):e583-e592. doi: 10.1016/S2352-3026(21)00169-1. Epub 2021 Jul 2.
9
Assessment of an Online Tool to Simulate the Effect of Pooled Testing for SARS-CoV-2 Detection in Asymptomatic and Symptomatic Populations.评估一种在线工具，以模拟在无症状和有症状人群中进行 SARS-CoV-2 检测的混样检测效果。
JAMA Netw Open. 2020 Dec 1;3(12):e2031517. doi: 10.1001/jamanetworkopen.2020.31517.
10
Association Between Exposure Characteristics and the Risk for COVID-19 Infection Among Health Care Workers With and Without BNT162b2 Vaccination.医护人员接种 BNT162b2 疫苗前后的暴露特征与 COVID-19 感染风险的相关性。
JAMA Netw Open. 2021 Sep 1;4(9):e2125394. doi: 10.1001/jamanetworkopen.2021.25394.
引用本文的文献
1
SARS-CoV-2 seroprevalence screening study of a children's hospital health care workers.一家儿童医院医护人员的新型冠状病毒2型血清流行率筛查研究
J Infect Prev. 2024 Nov;25(6):206-213. doi: 10.1177/17571774241245260. Epub 2024 Apr 14.
2
The Dynamic Risk of COVID-19-Related Events in Vaccinated Healthcare Workers (HCWs) from a Tertiary Hospital in Bucharest, Romania: A Study Based on Active Surveillance Data.罗马尼亚布加勒斯特一家三级医院接种疫苗的医护人员中与 COVID-19 相关事件的动态风险：一项基于主动监测数据的研究
Vaccines (Basel). 2024 Feb 11;12(2):182. doi: 10.3390/vaccines12020182.
3
Association between SARS-CoV-2 Symptoms, Ct Values, and Serological Response in Vaccinated and Unvaccinated Healthcare Personnel.接种和未接种医护人员的 SARS-CoV-2 症状、Ct 值和血清学反应之间的关系。
J Appl Lab Med. 2023 Sep 7;8(5):871-886. doi: 10.1093/jalm/jfad042.
4
Primary series COVID-19 vaccine effectiveness among healthcare workers in Albania, February-December 2021.2021年2月至12月阿尔巴尼亚医护人员中新冠病毒肺炎初级系列疫苗的有效性
IJID Reg. 2023 Sep;8:19-27. doi: 10.1016/j.ijregi.2023.04.009. Epub 2023 Apr 16.
5
Humoral and Cellular Response and Associated Variables Nine Months following BNT162b2 Vaccination in Healthcare Workers.医护人员接种BNT162b2疫苗九个月后的体液和细胞反应及相关变量
J Clin Med. 2023 Apr 28;12(9):3172. doi: 10.3390/jcm12093172.
6
Divalent siRNAs are bioavailable in the lung and efficiently block SARS-CoV-2 infection.二价 siRNA 在肺部具有生物利用度，并能有效阻止 SARS-CoV-2 感染。
Proc Natl Acad Sci U S A. 2023 Mar 14;120(11):e2219523120. doi: 10.1073/pnas.2219523120. Epub 2023 Mar 9.
7
Retrospective, Observational Studies for Estimating Vaccine Effects on the Secondary Attack Rate of SARS-CoV-2.回顾性观察研究估计疫苗对 SARS-CoV-2 二次攻击率的影响。
Am J Epidemiol. 2023 Jun 2;192(6):1016-1028. doi: 10.1093/aje/kwad046.
8
Risk of hospitalization and vaccine effectiveness among COVID-19 patients in the UAE during the Delta and Omicron outbreaks.阿联酋在德尔塔和奥密克戎变异株流行期间 COVID-19 患者住院风险和疫苗有效性。
Front Immunol. 2023 Feb 13;14:1049393. doi: 10.3389/fimmu.2023.1049393. eCollection 2023.
9
Epidemiology and Clinical Presentation of COVID-19 in Older Adults.老年人 COVID-19 的流行病学和临床表现。
Infect Dis Clin North Am. 2023 Mar;37(1):1-26. doi: 10.1016/j.idc.2022.11.001. Epub 2022 Nov 4.
10
Neutralizing antibodies after three doses of the BNT162b2 vaccine, breakthrough infection, and symptoms during the Omicron-predominant wave.接种三剂 BNT162b2 疫苗后的中和抗体、突破性感染和奥密克戎为主的流行期间的症状。
Int J Infect Dis. 2023 Mar;128:347-354. doi: 10.1016/j.ijid.2023.01.023. Epub 2023 Jan 22.
本文引用的文献
1
BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting.BNT162b2 mRNA 新冠病毒疫苗在全国大规模疫苗接种环境中的效果。
N Engl J Med. 2021 Apr 15;384(15):1412-1423. doi: 10.1056/NEJMoa2101765. Epub 2021 Feb 24.
2
Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients.BNT162b2疫苗接种者中SARS-CoV-2感染和新冠肺炎的早期感染率降低情况。
Lancet. 2021 Mar 6;397(10277):875-877. doi: 10.1016/S0140-6736(21)00448-7. Epub 2021 Feb 18.
3
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.BNT162b2 mRNA 新冠病毒疫苗的安全性和有效性。
N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.
4
Recommendations for the use of Taylor series confidence intervals for estimates of vaccine efficacy.关于使用泰勒级数置信区间估计疫苗效力的建议。
Bull World Health Organ. 1988;66(1):99-105.
Zotero 插件